Qiagen stock: JPMorgan raised target for Qiagen stock to USD 55.00
Published on 10/21/2026 at 15:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget and earnings figures
- JPMorgan raised Qiagen's target to USD 55.00 on October 14, 2026.
- Second-quarter revenue reached USD 535.04 million, USD 7.54 million above estimates.
- Qiagen stock costs EUR 42.81 at Lang & Schwarz on October 21, 2026 at 3:02 p.m. CEST, 0.05 percent below the Xetra close of October 20, 2026.
Qiagen (ISIN NL0015002SN0) has a fresh USD 55.00 price target from JPMorgan, raised from USD 50.00 in a note dated October 14, 2026, as reported by MarketBeat. Against the NYSE close of USD 48.90 on October 20, 2026, the target is 12.47 percent above the price. Qiagen stock was trading at EUR 42.81 at Lang & Schwarz on October 21, 2026 at 3:02 p.m. CEST, 0.05 percent below the Xetra close of October 20, 2026 at EUR 42.83.
Revenue beat expectations
Qiagen reported second-quarter 2026 revenue of USD 535.04 million, compared with USD 527.50 million in consensus estimates. Its adjusted earnings per share reached USD 0.62 against USD 0.60 expected, according to MarketBeat in its October 14, 2026 report.
Price position remains contained
On the NYSE, Qiagen closed at USD 48.90 on October 20, 2026. The session range was USD 46.62 to USD 50.82, with 10,131,442 shares traded; the 52-week range stood at USD 32.53 to USD 57.82. The same session placed the stock 15.42 percent below its 52-week high, while the market capitalization was USD 10.1 billion.
What does the target imply?
The JPMorgan target sits above the current U.S. price, while MarketBeat reported a broader average rating of Hold and a consensus target of USD 43.93 on October 14, 2026. Qiagen's trailing price-to-earnings ratio was 25.08 and its dividend yield was 0.05 percent as of October 20, 2026. The valuation therefore sits above the reported consensus target but below JPMorgan's objective.
The euro quote stays near EUR 42.83
At Lang & Schwarz, Qiagen stock stood at EUR 42.81 on October 21, 2026 at 3:02 p.m. CEST, down 0.05 percent versus the Xetra close of October 20, 2026 at EUR 42.83. The small euro-market gap contrasts with the wider 12.47 percent distance between the NYSE price and JPMorgan's USD 55.00 target.
The further course of trading is shown by the continuously updated real-time quote of Qiagen stock.
Qiagen market data
- Company: Qiagen N.V.
- ISIN: NL0015002SN0
- Ticker: QGEN
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 21, 2026, 3:02 p.m. CEST): EUR 42.81
- Change versus Xetra close: minus 0.05 percent
- Xetra close (October 20, 2026): EUR 42.83
- Market capitalization: USD 10.1 billion (as of October 20, 2026)
- 52-week range: USD 32.53-USD 57.82 (as of October 20, 2026)
- Sector / Industry: Health care / diagnostics and research services
- Index membership: DAX
Market context: Market report S&P 500.
